Adherence to antiretroviral therapy and treatment outcomes among conflict-affected and forcibly displaced populations: a systematic review
Open Access
- 31 October 2012
- journal article
- review article
- Published by Springer Science and Business Media LLC in Conflict and Health
- Vol. 6 (1), 9
- https://doi.org/10.1186/1752-1505-6-9
Abstract
Optimal adherence to highly active antiretroviral therapy (HAART) is required to promote viral suppression and to prevent disease progression and mortality. Forcibly displaced and conflict-affected populations may face challenges succeeding on HAART. We performed a systematic review of the literature on adherence to HAART and treatment outcomes in these groups, including refugees and internally-displaced persons (IDPs), assessed the quality of the evidence and suggest a future research program. Medline, Embase, and Global Health databases for 1995-2011 were searched using the Ovid platform. A backward citation review of subsequent work that had cited the Ovid results was performed using the Web of Science database. ReliefWeb and Médecins Sans Frontières (MSF) websites were searched for additional grey literature. We screened 297 records and identified 17 reports covering 15 quantitative and two qualitative studies from 13 countries. Three-quarters (11/15) of the quantitative studies were retrospective studies based on chart review; five studies included <100 clients. Adherence or treatment outcomes were reported in resettled refugees, conflict-affected persons, internally-displaced persons (IDPs), and combinations of refugees, IDPs and other foreign-born persons. The reviewed reports showed promise for conflict-affected and forcibly-displaced populations; the range of optimal adherence prevalence reported was 87-99.5%. Treatment outcomes, measured using virological, immunological and mortality estimates, were good in relation to non-affected groups. Given the diversity of settings where forcibly-displaced and conflict-affected persons access ART, further studies on adherence and treatment outcomes are needed to support scale-up and provide evidence-based justifications for inclusion of these vulnerable groups in national treatment plans. Future studies and program evaluations should focus on systematic monitoring of adherence and treatment interruptions by using facility-based pharmacy records, understanding threats to optimal adherence and timely linkage to care throughout the displacement cycle, and testing interventions designed to support adherence and treatment outcomes in these settings.Keywords
This publication has 34 references indexed in Scilit:
- The consequences of post-election violence on antiretroviral HIV therapy in KenyaAIDS Care, 2011
- High level of adherence to HAART among refugees and internally displaced persons on HAART in western equatorial region of Southern SudanJournal of the International AIDS Society, 2010
- Provision of antiretroviral treatment in conflict settings: the experience of Médecins Sans FrontièresConflict and Health, 2010
- Mortality and health among internally displaced persons in western Kenya following post-election violence, 2008: novel use of demographic surveillanceBulletin of the World Health Organization, 2010
- Good treatment outcomes among foreigners receiving antiretroviral therapy in Johannesburg, South AfricaInternational Journal of STD & AIDS, 2009
- Providing antiretroviral care in conflict settings.Current HIV/AIDS Reports, 2009
- Adherence to Antiretroviral Therapy in Conflict Areas: A Study among Patients Receiving Treatment from Lacor Hospital, UgandaAIDS Patient Care and STDs, 2009
- Combination antiretroviral therapy in population affected by conflict: outcomes from large cohort in northern UgandaBMJ, 2009
- Universal access: the benefits and challenges in bringing integrated HIV care to isolated and conflict affected populations in the Republic of CongoConflict and Health, 2009
- HIV Treatment in a Conflict Setting: Outcomes and Experiences from Bukavu, Democratic Republic of the CongoPLoS Medicine, 2007